About this trial
This study will evaluate the feasibility of three times weekly symptom reporting by children using the SPARK platform for 8 weeks. SPARK is a web-based application that promotes symptom screening for children receiving cancer therapies and enables access to clinical practice guidelines for symptom management. Newly diagnosed and relapsed patients with cancer will be enrolled. Children and/or their guardian will be prompted to complete symptom screening three times weekly via SPARK with corresponding feedback sent to their healthcare providers with each completed assessment. Symptom reports will contain links to clinical practice guidelines for symptom management. Active intervention will last for 8 weeks starting from the date of enrollment.
Eligibility criteria
Qualifiers
cancer diagnosis
2-18 years of age at enrollment
Child has received or a plan for any chemotherapy, radiotherapy or surgery
Understands English, French or Spanish
Disqualifiers
Cognitive disability
Visual impairment (cannot see SPARK even with corrective lens)
Trial design
Treatments tested in this trial
- SPARK